Meet Us at Bio-Europe 2024!
Experimentica will be presenting preclinical ocular models at Bio-Europe 2024 in Stockholm, Nov. 4-6, 2024.
Learn more
Kon’nichiwa BioJapan 2024!
Experimentica will be presenting preclinical ocular models at BioJapan 2024 in Yokohama, Oct. 9-11, 2024.
Learn more
Meet Experimentica at the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston
Experimentica attends the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston, Sept. 10-12, 2024.
Learn more
Experimentica attends ARVO 2024 (booth #1440)
Experimentica is pleased to announce its participation in the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2024.
Learn more
Experimentica Ltd. renews French CIR accreditation
France's Crédit d'Impôt Recherche incentive can cover up to 30% of R&D expenses incurred by innovative French pharma and biotech companies working with Experimentica.
Learn more
Experimentica Science Day | May 26, 2023, Vilnius, LT
Experimentica Science Day: connect with top preclinical Ophthalmology Professors and Industry Experts for insights and discoveries
Learn more
Experimentica-led NeoVasculoStop Consortium Awarded 3 M€ European Innovation Council Pathfinder Grant
Focus is to develop innovative oral treatments for retinal diseases caused by neovascularization and to improve the safety of anti-angiogenic therapies for patients.
Learn more
